LPL Financial’s Global Blood Therapeutics, Inc. GBT Stock Holding History

LPL Financial’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-3,419	Closed	-$233K	–	4649
2022 Q3	$233K	Buy	+3,419	New	+$189K	﹤0.01%	3802
2020 Q1	–	Sell	-26,897	Closed	-$2.14M	–	3470
2019 Q4	$2.14M	Buy	+26,897	New	+$1.59M	﹤0.01%	1312
2019 Q3	–	Sell	-4,169	Closed	-$219K	–	3395
2019 Q2	$219K	Buy	+4,169	New	+$240K	﹤0.01%	2954
2017 Q2	–	Sell	-10,616	Closed	-$389K	–	2999
2017 Q1	$389K	Buy	+10,616	New	+$267K	﹤0.01%	2011

Other funds holding GBT

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

LPL Financial's GBT Position: Q4 2022 in Review

LPL Financial sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 3,419 shares — an estimated $233K sold.

LPL Financial first reported a position in GBT in Q1 2017 and held it in 4 quarters. The position peaked at $2.14M in Q4 2019. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

LPL Financial reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
LPL Financial sold 3,419 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $233K.
LPL Financial first reported a position in Global Blood Therapeutics, Inc. in Q1 2017 and held it in 4 quarters.
LPL Financial's Global Blood Therapeutics, Inc. position peaked at $2.14M in Q4 2019.
2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on LPL Financial's 13F filing for Q4 2022, filed 7 Feb 2023.